Protagonist Therapeutics Inc (PTGX)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 252,843 | -93,652 | -131,373 | -125,845 | -64,516 |
| Revenue | US$ in thousands | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
| Operating profit margin | 58.20% | -156.09% | -494.24% | -460.01% | -225.36% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $252,843K ÷ $434,433K
= 58.20%
Protagonist Therapeutics Inc's operating profit margin has shown significant fluctuations over the years. The company experienced negative operating profit margins in 2020, 2021, 2022, and 2023, indicating that its operating expenses exceeded its gross profit during those periods. However, in 2024, the operating profit margin drastically improved to a positive 58.20%, suggesting that the company was able to effectively control its operating expenses and enhance operational efficiency. It is crucial for Protagonist Therapeutics Inc to sustain and further improve this positive trend to ensure long-term profitability and financial stability.
Peer comparison
Dec 31, 2024